ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Winners Of ASCO 2012
Seeking Alpha
ASCO Data Suggest Dendreon's Provenge Should Go First
Seeking Alpha
Study of Treanda shows great promise for Teva's drug
Fierce Pharma
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
ASCO Stocks To Consider This Week
Seeking Alpha

